First-half 2014 medtech acquisition values surpasses 2013 in total

By

First-half medtech acquisition value surpasses 2013 total  (EP Vantage)

Source
EP Vantage

Company
Thermo Fisher Scientific, Abbott Laboratories, Ansell, Bausch + Lomb, Baxter International, Bayer, bioMérieux, Cardinal Health, CareFusion, Covidien, Essilor International, Grifols, Illumina, Johnson & Johnson, Kinetic Concepts, Medtronic, MicroPort Scientific, Novartis, Smith & Nephew, Stryker, Valeant Pharmaceuticals International

Tags
Analysis, Company Strategy, Medtech, Subsidiary, Disposal, Acquisition, Merger, Free Content

Date
July 22, 2014

Large medtech companies seem t...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.